カテゴリー： QYResearch, 世界

腫瘍特異抗原の世界市場：規模・現状・予測

◆英語タイトル：Global Tumor-Specific Antigen Market Size, Status and Forecast 2019-2025
◆商品コード：DATA909X19057
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月25日（※2024年版があります。お問い合わせください）
◆ページ数：91
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,900 ⇒換算￥577,200	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,850 ⇒換算￥865,800	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,800 ⇒換算￥1,154,400	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※当調査レポートでは、腫瘍特異抗原の世界市場について調査・分析し、腫瘍特異抗原の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（コーディング領域、非コーディング領域）、用途別（創薬、開発、診断、臨床＆基礎研究、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。

・レポートの概要
・世界の腫瘍特異抗原市場動向
・主要企業別マーケットシェア
・腫瘍特異抗原の種類別市場規模2014-2019
（コーディング領域、非コーディング領域）
・腫瘍特異抗原の用途別市場規模2014-2019
（創薬、開発、診断、臨床＆基礎研究、その他）
・腫瘍特異抗原の北米市場：主要企業・種類別/用途別市場規模
・腫瘍特異抗原のヨーロッパ市場：主要企業・種類別/用途別市場規模
・腫瘍特異抗原の中国市場：主要企業・種類別/用途別市場規模
・腫瘍特異抗原の日本国内市場：主要企業・種類別/用途別市場規模
・腫瘍特異抗原の東南アジア市場：主要企業・種類別/用途別市場規模
・腫瘍特異抗原のインド市場：主要企業・種類別/用途別市場規模
・腫瘍特異抗原の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Agilent Technologies、Creative Diagnostics、Go Therapeutics、Lee Biosolutions、Bio-Rad、Biomrieux、Caris Life Sciences、Roche、Abcam、Merck Group、PerkinElmer、OriGene Technologies）
・腫瘍特異抗原の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...

【レポートの概要】

Tumor-specific Antigen is a new Antigen that is expressed on the surface of certain Tumor cells but not on normal cells.Such antigens may be present in tumors of the same tissue type in different individuals.Tumor-specific antigens help the body develop an immune response to cancer cells.They could be used as potential targets for targeted therapy or immunotherapy to help improve the body’s immune system to kill more cancer cells.Tumor-specific antigens can also be used in laboratory tests to help identify certain types of cancer.In 2018, the global Tumor-Specific Antigen market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Tumor-Specific Antigen status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Tumor-Specific Antigen development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Agilent Technologies
Creative Diagnostics
Go Therapeutics
Lee Biosolutions
Bio-Rad
Biomrieux
Caris Life Sciences
Roche
Abcam
Merck Group
PerkinElmer
OriGene Technologies

Market segment by Type, the product can be split into
Coding Region
Non-Coding Region

Market segment by Application, split into
Drug Discovery and Development
Diagnostics
Clinical and Basic Research
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Tumor-Specific Antigen status, future forecast, growth opportunity, key market and key players.
To present the Tumor-Specific Antigen development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Tumor-Specific Antigen are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Tumor-Specific Antigen Market Size Growth Rate by Type (2014-2025)
1.4.2 Coding Region
1.4.3 Non-Coding Region
1.5 Market by Application
1.5.1 Global Tumor-Specific Antigen Market Share by Application (2019-2025)
1.5.2 Drug Discovery and Development
1.5.3 Diagnostics
1.5.4 Clinical and Basic Research
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Tumor-Specific Antigen Market Size
2.2 Tumor-Specific Antigen Growth Trends by Regions
2.2.1 Tumor-Specific Antigen Market Size by Regions (2019-2025)
2.2.2 Tumor-Specific Antigen Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Tumor-Specific Antigen Market Size by by Players
3.1.1 Global Tumor-Specific Antigen Revenue by by Players (2014-2019)
3.1.2 Global Tumor-Specific Antigen Revenue Market Share by by Players (2014-2019)
3.1.3 Global Tumor-Specific Antigen Market Concentration Ratio (CR5 and HHI)
3.2 Tumor-Specific Antigen Key Players Head office and Area Served
3.3 Key Players Tumor-Specific Antigen Product/Solution/Service
3.4 Date of Enter into Tumor-Specific Antigen Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Tumor-Specific Antigen Market Size by Type (2014-2019)
4.2 Global Tumor-Specific Antigen Market Size by Application (2014-2019)

5 North America
5.1 North America Tumor-Specific Antigen Market Size (2014-2019)
5.2 Tumor-Specific Antigen Key Players in North America
5.3 North America Tumor-Specific Antigen Market Size by Type
5.4 North America Tumor-Specific Antigen Market Size by Application

6 Europe
6.1 Europe Tumor-Specific Antigen Market Size (2014-2019)
6.2 Tumor-Specific Antigen Key Players in Europe
6.3 Europe Tumor-Specific Antigen Market Size by Type
6.4 Europe Tumor-Specific Antigen Market Size by Application

7 China
7.1 China Tumor-Specific Antigen Market Size (2014-2019)
7.2 Tumor-Specific Antigen Key Players in China
7.3 China Tumor-Specific Antigen Market Size by Type
7.4 China Tumor-Specific Antigen Market Size by Application

8 Japan
8.1 Japan Tumor-Specific Antigen Market Size (2014-2019)
8.2 Tumor-Specific Antigen Key Players in Japan
8.3 Japan Tumor-Specific Antigen Market Size by Type
8.4 Japan Tumor-Specific Antigen Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Tumor-Specific Antigen Market Size (2014-2019)
9.2 Tumor-Specific Antigen Key Players in Southeast Asia
9.3 Southeast Asia Tumor-Specific Antigen Market Size by Type
9.4 Southeast Asia Tumor-Specific Antigen Market Size by Application

10 India
10.1 India Tumor-Specific Antigen Market Size (2014-2019)
10.2 Tumor-Specific Antigen Key Players in India
10.3 India Tumor-Specific Antigen Market Size by Type
10.4 India Tumor-Specific Antigen Market Size by Application

11 Central & South America
11.1 Central & South America Tumor-Specific Antigen Market Size (2014-2019)
11.2 Tumor-Specific Antigen Key Players in Central & South America
11.3 Central & South America Tumor-Specific Antigen Market Size by Type
11.4 Central & South America Tumor-Specific Antigen Market Size by Application

12 International Players Profiles
12.1 Agilent Technologies
12.1.1 Agilent Technologies Company Details
12.1.2 Company Description and Business Overview
12.1.3 Tumor-Specific Antigen Introduction
12.1.4 Agilent Technologies Revenue in Tumor-Specific Antigen Business (2014-2019))
12.1.5 Agilent Technologies Recent Development
12.2 Creative Diagnostics
12.2.1 Creative Diagnostics Company Details
12.2.2 Company Description and Business Overview
12.2.3 Tumor-Specific Antigen Introduction
12.2.4 Creative Diagnostics Revenue in Tumor-Specific Antigen Business (2014-2019)
12.2.5 Creative Diagnostics Recent Development
12.3 Go Therapeutics
12.3.1 Go Therapeutics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Tumor-Specific Antigen Introduction
12.3.4 Go Therapeutics Revenue in Tumor-Specific Antigen Business (2014-2019)
12.3.5 Go Therapeutics Recent Development
12.4 Lee Biosolutions
12.4.1 Lee Biosolutions Company Details
12.4.2 Company Description and Business Overview
12.4.3 Tumor-Specific Antigen Introduction
12.4.4 Lee Biosolutions Revenue in Tumor-Specific Antigen Business (2014-2019)
12.4.5 Lee Biosolutions Recent Development
12.5 Bio-Rad
12.5.1 Bio-Rad Company Details
12.5.2 Company Description and Business Overview
12.5.3 Tumor-Specific Antigen Introduction
12.5.4 Bio-Rad Revenue in Tumor-Specific Antigen Business (2014-2019)
12.5.5 Bio-Rad Recent Development
12.6 Biomrieux
12.6.1 Biomrieux Company Details
12.6.2 Company Description and Business Overview
12.6.3 Tumor-Specific Antigen Introduction
12.6.4 Biomrieux Revenue in Tumor-Specific Antigen Business (2014-2019)
12.6.5 Biomrieux Recent Development
12.7 Caris Life Sciences
12.7.1 Caris Life Sciences Company Details
12.7.2 Company Description and Business Overview
12.7.3 Tumor-Specific Antigen Introduction
12.7.4 Caris Life Sciences Revenue in Tumor-Specific Antigen Business (2014-2019)
12.7.5 Caris Life Sciences Recent Development
12.8 Roche
12.8.1 Roche Company Details
12.8.2 Company Description and Business Overview
12.8.3 Tumor-Specific Antigen Introduction
12.8.4 Roche Revenue in Tumor-Specific Antigen Business (2014-2019)
12.8.5 Roche Recent Development
12.9 Abcam
12.9.1 Abcam Company Details
12.9.2 Company Description and Business Overview
12.9.3 Tumor-Specific Antigen Introduction
12.9.4 Abcam Revenue in Tumor-Specific Antigen Business (2014-2019)
12.9.5 Abcam Recent Development
12.10 Merck Group
12.10.1 Merck Group Company Details
12.10.2 Company Description and Business Overview
12.10.3 Tumor-Specific Antigen Introduction
12.10.4 Merck Group Revenue in Tumor-Specific Antigen Business (2014-2019)
12.10.5 Merck Group Recent Development
12.11 PerkinElmer
12.12 OriGene Technologies

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Tumor-Specific Antigen Key Market Segments
Table Key Players Tumor-Specific Antigen Covered
Table Global Tumor-Specific Antigen Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Coding Region Figures
Table Key Players of Coding Region
Figuer Non-Coding Region Figures
Table Key Players of Non-Coding Region
Table Global Tumor-Specific Antigen Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Tumor-Specific Antigen Market Share by Application in 2018 & 2025
Figure Drug Discovery and Development Case Studies
Figure Diagnostics Case Studies
Figure Clinical and Basic Research Case Studies
Figure Others Case Studies
Figure Tumor-Specific Antigen Report Years Considered
Figure Global Tumor-Specific Antigen Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Tumor-Specific Antigen Market Size by Regions 2019-2025 (Million US$)
Table Global Tumor-Specific Antigen Market Size by Regions 2019-2025 (Million US$)
Table Global Tumor-Specific Antigen Market Share by Regions 2014-2019
Figure Global Tumor-Specific Antigen Market Share by Regions 2014-2019
Figure Global Tumor-Specific Antigen Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Tumor-Specific Antigen Revenue by by Players (2014-2019) (Million US$)
Table Global Tumor-Specific Antigen Market Share by by Players (2014-2019)
Figure Global Tumor-Specific Antigen Market Share by by Players in 2018
Table Global Tumor-Specific Antigen by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Tumor-Specific Antigen Product/Solution/Service
Table Date of Enter into Tumor-Specific Antigen Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Tumor-Specific Antigen Market Size by Type (2014-2019) (Million US$)
Table Global Tumor-Specific Antigen Market Size Share by Type (2014-2019)
Figure Global Tumor-Specific Antigen Market Size Market Share by Type (2014-2019)
Table Global Tumor-Specific Antigen Market Size by Application (2014-2019) (Million US$)
Table Global Tumor-Specific Antigen Market Size Share by Application (2014-2019)
Figure Global Tumor-Specific Antigen Market Size Market Share by Application (2014-2019)
Figure Global Tumor-Specific Antigen Revenue Market Share by Application in 2018
Figure North America Tumor-Specific Antigen Market Size 2014-2019 (Million US$)
Table North America Key Players Tumor-Specific Antigen Revenue (2018-2019) (Million US$)
Table North America Key Players Tumor-Specific Antigen Market Share (2018-2019)
Table North America Tumor-Specific Antigen Market Size by Type 2014-2019 (Million US$)
Table North America Tumor-Specific Antigen Market Share by Type 2014-2019
Table North America Tumor-Specific Antigen Market Size by Application 2014-2019 (Million US$)
Table North America Tumor-Specific Antigen Market Share by Application 2014-2019
Figure Europe Tumor-Specific Antigen Market Size 2014-2019 (Million US$)
Table Europe Key Players Tumor-Specific Antigen Revenue (2018-2019) (Million US$)
Table Europe Key Players Tumor-Specific Antigen Market Share (2018-2019)
Table Europe Tumor-Specific Antigen Market Size by Type 2014-2019 (Million US$)
Table Europe Tumor-Specific Antigen Market Share by Type 2014-2019
Table Europe Tumor-Specific Antigen Market Size by Application 2014-2019 (Million US$)
Table Europe Tumor-Specific Antigen Market Share by Application 2014-2019
Figure China Tumor-Specific Antigen Market Size 2014-2019 (Million US$)
Table China Key Players Tumor-Specific Antigen Revenue (2018-2019) (Million US$)
Table China Key Players Tumor-Specific Antigen Market Share (2018-2019)
Table China Tumor-Specific Antigen Market Size by Type 2014-2019 (Million US$)
Table China Tumor-Specific Antigen Market Share by Type 2014-2019
Table China Tumor-Specific Antigen Market Size by Application 2014-2019 (Million US$)
Table China Tumor-Specific Antigen Market Share by Application 2014-2019
Figure Japan Tumor-Specific Antigen Market Size 2014-2019 (Million US$)
Table Japan Key Players Tumor-Specific Antigen Revenue (2018-2019) (Million US$)
Table Japan Key Players Tumor-Specific Antigen Market Share (2018-2019)
Table Japan Tumor-Specific Antigen Market Size by Type 2014-2019 (Million US$)
Table Japan Tumor-Specific Antigen Market Share by Type 2014-2019
Table Japan Tumor-Specific Antigen Market Size by Application 2014-2019 (Million US$)
Table Japan Tumor-Specific Antigen Market Share by Application 2014-2019
Figure Southeast Asia Tumor-Specific Antigen Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Tumor-Specific Antigen Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Tumor-Specific Antigen Market Share (2018-2019)
Table Southeast Asia Tumor-Specific Antigen Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Tumor-Specific Antigen Market Share by Type 2014-2019
Table Southeast Asia Tumor-Specific Antigen Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Tumor-Specific Antigen Market Share by Application 2014-2019
Figure India Tumor-Specific Antigen Market Size 2014-2019 (Million US$)
Table India Key Players Tumor-Specific Antigen Revenue (2018-2019) (Million US$)
Table India Key Players Tumor-Specific Antigen Market Share (2018-2019)
Table India Tumor-Specific Antigen Market Size by Type 2014-2019 (Million US$)
Table India Tumor-Specific Antigen Market Share by Type 2014-2019
Table India Tumor-Specific Antigen Market Size by Application 2014-2019 (Million US$)
Table India Tumor-Specific Antigen Market Share by Application 2014-2019
Figure Central & South America Tumor-Specific Antigen Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Tumor-Specific Antigen Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Tumor-Specific Antigen Market Share (2018-2019)
Table Central & South America Tumor-Specific Antigen Market Size by Type 2014-2019 (Million US$)
Table Central & South America Tumor-Specific Antigen Market Share by Type 2014-2019
Table Central & South America Tumor-Specific Antigen Market Size by Application 2014-2019 (Million US$)
Table Central & South America Tumor-Specific Antigen Market Share by Application 2014-2019
Table Agilent Technologies Company Details
Table Agilent Technologies Revenue in Tumor-Specific Antigen Business 2014-2019 (Million US$)
Figure Agilent Technologies Revenue Growth Rate in Tumor-Specific Antigen Business (2014-2019)
Table Agilent Technologies Recent Development
Table Creative Diagnostics Company Details
Table Creative Diagnostics Revenue in Tumor-Specific Antigen Business 2014-2019 (Million US$)
Figure Creative Diagnostics Revenue Growth Rate in Tumor-Specific Antigen Business (2014-2019)
Table Creative Diagnostics Recent Development
Table Go Therapeutics Company Details
Table Go Therapeutics Revenue in Tumor-Specific Antigen Business 2014-2019 (Million US$)
Figure Go Therapeutics Revenue Growth Rate in Tumor-Specific Antigen Business (2014-2019)
Table Go Therapeutics Recent Development
Table Lee Biosolutions Company Details
Table Lee Biosolutions Revenue in Tumor-Specific Antigen Business 2014-2019 (Million US$)
Figure Lee Biosolutions Revenue Growth Rate in Tumor-Specific Antigen Business (2014-2019)
Table Lee Biosolutions Recent Development
Table Bio-Rad Company Details
Table Bio-Rad Revenue in Tumor-Specific Antigen Business 2014-2019 (Million US$)
Figure Bio-Rad Revenue Growth Rate in Tumor-Specific Antigen Business (2014-2019)
Table Bio-Rad Recent Development
Table Biomrieux Company Details
Table Biomrieux Revenue in Tumor-Specific Antigen Business 2014-2019 (Million US$)
Figure Biomrieux Revenue Growth Rate in Tumor-Specific Antigen Business (2014-2019)
Table Biomrieux Recent Development
Table Caris Life Sciences Company Details
Table Caris Life Sciences Revenue in Tumor-Specific Antigen Business 2014-2019 (Million US$)
Figure Caris Life Sciences Revenue Growth Rate in Tumor-Specific Antigen Business (2014-2019)
Table Caris Life Sciences Recent Development
Table Roche Company Details
Table Roche Revenue in Tumor-Specific Antigen Business 2014-2019 (Million US$)
Figure Roche Revenue Growth Rate in Tumor-Specific Antigen Business (2014-2019)
Table Roche Recent Development
Table Abcam Company Details
Table Abcam Revenue in Tumor-Specific Antigen Business 2014-2019 (Million US$)
Figure Abcam Revenue Growth Rate in Tumor-Specific Antigen Business (2014-2019)
Table Abcam Recent Development
Table Merck Group Company Details
Table Merck Group Revenue in Tumor-Specific Antigen Business 2014-2019 (Million US$)
Figure Merck Group Revenue Growth Rate in Tumor-Specific Antigen Business (2014-2019)
Table Merck Group Recent Development
Table PerkinElmer Company Details
Table OriGene Technologies Company Details
Table Global Tumor-Specific Antigen Market Size by Regions (Million US$) 2019-2025
Figure Global Tumor-Specific Antigen Market Size Share by Regions (2019-2025)
Figure Global Tumor-Specific Antigen Market Size Share by Regions in 2025
Figure North America Tumor-Specific Antigen Market Size Forecast (2019-2025)(Million USD)
Figure Europe Tumor-Specific Antigen Market Size Forecast (2019-2025)(Million USD)
Figure China Tumor-Specific Antigen Market Size Forecast (2019-2025)(Million USD)
Figure Japan Tumor-Specific Antigen Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Tumor-Specific Antigen Market Size Forecast (2019-2025)(Million USD)
Figure India Tumor-Specific Antigen Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Tumor-Specific Antigen Market Size Forecast (2019-2025)(Million USD)
Table Global Tumor-Specific Antigen Market Size by Product (2019-2025) (Million US$)
Figure Global Tumor-Specific Antigen Market Size by Product (2019-2025)
Figure Global Tumor-Specific Antigen Market Size by Product in 2025
Table Global Tumor-Specific Antigen Market Size by Application (2019-2025) (Million US$)
Figure Global Tumor-Specific Antigen Market Size by Application (2019-2025)
Figure Global Tumor-Specific Antigen Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

Agilent Technologies、Creative Diagnostics、Go Therapeutics、Lee Biosolutions、Bio-Rad、Biomrieux、Caris Life Sciences、Roche、Abcam、Merck Group、PerkinElmer、OriGene Technologies

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 腫瘍特異抗原の世界市場：規模・現状・予測(Global Tumor-Specific Antigen Market Size, Status and Forecast 2019-2025)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp